ZNF460 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.546200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.732200E-01
Normal-vs-Stage2
6.036000E-01
Normal-vs-Stage3
2.645200E-01
Normal-vs-Stage4
4.853800E-01
Stage1-vs-Stage2
1.835760E-01
Stage1-vs-Stage3
1.423990E-01
Stage1-vs-Stage4
1.536150E-01
Stage2-vs-Stage3
3.000600E-01
Stage2-vs-Stage4
4.168300E-02
Stage3-vs-Stage4
5.760000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.021600E-01
Normal-vs-AfricanAmerican
8.182200E-01
Normal-vs-Asian
3.897800E-01
Caucasian-vs-AfricanAmerican
7.326200E-01
Caucasian-vs-Asian
7.163800E-03
AfricanAmerican-vs-Asian
5.134100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.288800E-01
Normal-vs-Female
4.859600E-01
Male-vs-Female
4.976400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.878400E-01
Normal-vs-Age(41-60Yrs)
8.181200E-01
Normal-vs-Age(61-80Yrs)
5.119800E-01
Normal-vs-Age(81-100Yrs)
4.034400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.983600E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.299400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.120200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.853000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.824600E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.000700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.792400E-01
Normal-vs-Daily Drinker
3.157400E-01
Normal-vs-Weekly Drinker
2.160400E-01
Normal-vs-Occasional Drinker
8.870200E-01
Normal-vs-Social Drinker
5.815800E-01
Non Drinker-vs-Daily Drinker
6.287000E-01
Non Drinker-vs-Weekly Drinker
5.042600E-01
Non Drinker-vs-Occasional Drinker
3.542600E-01
Non Drinker-vs-Social Drinker
8.851000E-01
Daily Drinker-vs-Weekly Drinker
8.814800E-01
Daily Drinker-vs-Occasional Drinker
1.183760E-01
Daily Drinker-vs-Social Drinker
5.091400E-01
Weekly Drinker-vs-Occasional Drinker
1.076160E-01
Weekly Drinker-vs-Social Drinker
4.359200E-01
Occasional Drinker-vs-Social Drinker
4.461600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.182200E-01
Normal-vs-Grade 2
1.326800E-01
Normal-vs-Grade 3
1.704980E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.004430E-01
Grade 1-vs-Grade 3
7.570200E-02
Grade 1-vs-Grade 4
3.182200E-01
Grade 2-vs-Grade 3
5.006200E-01
Grade 2-vs-Grade 4
1.326800E-01
Grade 3-vs-Grade 4
1.704980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.047600E-01
Normal-vs-NonDiabetic
4.868400E-01
Diabetic-vs-NonDiabetic
9.119400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.240600E-01
Normal-vs-NoPancreatitis
5.631400E-01
Pancreatitis-vs-NoPancreatitis
1.440240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.716000E-01
Normal-vs-N1
6.256800E-01
N0-vs-N1
5.326400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.660400E-01
Normal-vs-TP53-NonMutant
2.627200E-01
TP53-Mutant-vs-TP53-NonMutant
3.500100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
